Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1 | Zendy

Stefano Ferrari | Zendy; Pietro Ruggieri | Zendy; Graziella Cefalo | Zendy; Angela Tamburini | Zendy; Rodolfo Capanna | Zendy; Franca Fagioli | Zendy; Alessandro Comandone | Zendy; Rossella Bertulli | Zendy; Gianni Bisogno | Zendy; Emanuela Palmerini | Zendy; Marco Alberghini | Zendy; Antonina Parafioriti | Zendy; Alessandra Linari | Zendy; Piero Picci | Zendy; Gaetano Bacci | Zendy

Open Access

Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1

Author(s) -

Stefano Ferrari,

Pietro Ruggieri,

Graziella Cefalo,

Angela Tamburini,

Rodolfo Capanna,

Franca Fagioli,

Alessandro Comandone,

Rossella Bertulli,

Gianni Bisogno,

Emanuela Palmerini,

Marco Alberghini,

Antonina Parafioriti,

Alessandra Linari,

Piero Picci,

Gaetano Bacci

Publication year - 2012

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2011.38.4420

Subject(s) - medicine , ifosfamide , chemotherapy , methotrexate , osteosarcoma , surgery , doxorubicin , mesna , sarcoma , toxicity , cisplatin , cyclophosphamide , gastroenterology , urology , pathology

We compared two chemotherapy regimens that included methotrexate (MTX), cisplatin (CDP), and doxorubicin (ADM) with or without ifosfamide (IFO) in patients with nonmetastatic osteosarcoma of the extremity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research